EpimAb_LogoPlanegg/Martinsried and Shanghai, February 27, 2025. Medigene AG (Medigene, FSE: MDG1, Prime Standard) and EpimAb Biotherapeutics, Inc. (EpimAb), announced that the companies have entered ...

EpimAb_LogoPlanegg/Martinsried and Shanghai, February 27, 2025. Medigene AG (Medigene, FSE: MDG1, Prime Standard) and EpimAb Biotherapeutics, ...

Medigene AG, an oncology platform company focused on the research and development of T cell receptor (TCR)-guided therapies for the treatment of cancer, announced that the company has been issued a ...

Medigene continuously strengthens and expands its patent portfolio by developing new 3S TCRs, integrating advanced technologies, and extending its existing patents to new regions. The Company now owns ...

Data Generated to Date Support Potential for Aclaris’ ATI-2138 to Impact Several Human Inflammatory Diseases - WAYNE, Pa., Feb. 12, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: ACRS), a clinical-stage ...

He is behind the TCR Asia Series and is an advisor to the TCR UK Series. “I am proud to have the opportunity to manage TCR Australia, a series I have long regarded as one of the most competitive ...

A new TCR series in Panama will launch later this month after a six-year agreement was signed to introduce the regulations into the county. Autódromo Panamá has signed terms with WSC Group that will ...

The device serious enough to ignite my nervous energy is a Cupra Leon VZ TCR, aka the Spanish firm’s latest Touring Car. It’s eligible to compete in TCR-reg races across the globe including ...